Capital Fund Management S.A. Axsome Therapeutics, Inc. Transaction History

Capital Fund Management S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$39.94 - $79.72 $770,163 - $1.54 Million	19,283 New	19,283 $1.49 Million
Q2 2022 Aug 12, 2022	SELL	$21.74 - $46.75 $414,038 - $890,353	-19,045 Reduced 59.19%	13,133 $502,000
Q1 2022 May 12, 2022	BUY	$23.7 - $41.39 $762,618 - $1.33 Million	32,178 New	32,178 $1.33 Million

327

38M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.56B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.